THE MENOPAUSE DRUG FEMO-KLIM IS THE BEST NONHORMONAL SOLUTION OF HORMONAL PROBLEMS

DOI: https://doi.org/10.29296/25877305-2019-01-08
Download full text PDF
Issue: 
1
Year: 
2019

E. Petrova(1), Candidate of Medical Sciences, Associate Professor; V. Kalistratov(1), Candidate of Medical Sciences, Associate Professor; P. Polyboyarinov(2), Candidate of Agricultural Sciences; Professor V. Strukov(3), MD; M. Prokhorov(3); D. Elistratov(4) 1-Penza State University; 2-Penza State University of Architecture and Construction; 3-Penza Institute for Postgraduate Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; 4-OOO «Parafarm», Penza

The normal occurrence of physiological processes during menopause requires not only estrogens, but also sufficient androgens. The menopause medicine Femo-Klim has a complex versatile effect on the female body during its difficult period. It can safely normalize not only the level of estrogens, but also the concentration of androgens, significantly reduces even the most severe manifestations of perimenopause – hot flushes, reducing their number and strength. All components of the drug are physiologically close to the human body and do not impair its natural processes.

Keywords: 
menopause
female health
gynecology
phytoestrogens
phytoandrogens



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Petrova E.V., Elistratov D.G. Terapevticheskaya korrekciya e`rektil`noy disfunkcii i trevozhno-depressivnyh rasstroystv u pacientov s arterial`noy gipertenziey // Vrach. – 2016; 4: 78–82 [Petrova E., Elistratov D. Therapeutic correction of erectile dysfunction and anxiety and depressive disorders in hypertensive patients // Vrach. – 2016; 4: 78–82 (in Russ.)].
  2. Petrova E.V. i dr. Terapevticheskaya korrekciya urovnya degidroe`piandrosteron-sul`fata i testosterona pri seksual`nyh disfunkciyah // Vrach. – 2014; 1: 60–1 [Petrova E. et al. Therapeutical regulation of dehydroepiandrosterone sulfate and testosterone levels and sexual dysfunctions // Vrach. – 2014; 1: 60–1 (in Russ.)].
  3. Strukov V.I. i dr. Vliyanie Osteomeda Forte na gormonal`nyy status i techenie osteoporoza u zhenshhin s deficitom androgenov v postmenopauze // Vrach. – 2015; 3: 28–32 [Strukov V. et al. Effect of Osteomed Forte on hormonal status and course of osteoporosis in postmenopausal women with androgen deficiency // Vrach. – 2015; 3: 28–32 (in Russ.)].
  4. Kalinchenko S.Yu., Apetov S.S. Primenenie androgenov u zhenshhin v klimaktericheskom periode // Lechashhiy vrach. – 2009; 3: 28–30 [Kalinchenko S.YU., Apetov S.S. Primeneniye androgenov u zhenshchin v klimaktericheskom periode // Lechashchiy vrach. – 2009; 3: 28–30 (in Russ.)].
  5. Radzinskiy V. E., Kalinchenko S.Yu., Apetov S.S. Terapiya androgenami v ginekologicheskoy praktike // Vestnik RUDN, ser. Medicina. Akusherstvo i ginekologiya. – 2010; 6: 196–204 [Radzynskiy V.E., Kalinchenko S.Yu., Apetov S.S. Androgen therapy in gynecological practice // Vestnik RUDN, ser. Meditsina. Akusherstvo i ginekologiya. – 2010; 6: 196–204 (in Russ.)]
  6. Melikova A.V. Giperandrogeniya: mify i real`nost` // E`ffektivnaya farmakoterapiya. E`ndokrinologiya. – 2018; 3: 18–23 [Melikova A.V. Hyperandrogenia: Myths and Reality // Effektivnaya farmakoterapiya. Endokrinologiya. – 2018; 3: 18–23 (in Russ.)].
  7. Marchenko L.A., Il`ina L.M. Deficit androgenov u zhenshhin. Materialy Mezhdunarodnogo konsensusa dlya rassylki chlenam AGE` vo II kvartale 2005 goda [Marchenko L.A., Il'ina L.M. Defitsit androgenov u zhenshchin. Materialy Mezhdunarodnogo konsensusa dlya rassylki chlenam AGE vo II kvartale 2005 goda (in Russ.)].
  8. Radzinskiy V.E., Kalinchenko S.Yu., Apetov S.S. Sindrom deficita androgenov u zhenshhin // Vestnik RUDN, ser. Medicina. Akusherstvo i ginekologiya. – 2010; 6: 266–76 [Radzynskiy V.E., Kalinchenko S.Yu., Apetov S.S. Female androgen deficiency syndrome // Vestnik RUDN, ser. Meditsina. Akusherstvo i ginekologiya. – 2010; 6: 266–76 (in Russ.)].
  9. Tyuzikov I.A., Kalinchenko S.Yu., Apetov S.S. Deficit androgenov u zhenshhin v uroginekologicheskoy praktike: patofiziologiya, klinicheskie «maski» i farmakoterapiya s primeneniem transdersmal`nyh form testosterona // Ros. vestn. akushera-ginekologa. – 2014; 1: 33–43 [Tiuzikov I.A., Kalinchenko S.Iu., Apetov S.S. Androgen deficiency in women in urogynecologic practice: Pathophysiology, clinical «masks», and pharmacotherapy using transdermal testosterone formulations // Rossiyskiy vestnik akushera-ginekologa. – 2014; 1: 33–43 (in Russ.)].
  10. Apetov S.S., Kalinchenko S.Yu. Vliyanie deficita polovyh gormonov na zabolevaemost` i kachestvo zhizni zhenshhin s hirurgicheskoy menopauzoy // Vopr. ginekol., akusher. i perinatol. – 2012; 11: 72–8 [Apetov S.S., Kalinchenko S.Yu. An effect of sex hormones deficit on the morbidity and quality of life in women with surgical menopause // Voprosy ginekologii, akusherstva i perinatologii. – 2012; 11: 72–8 (in Russ.)].
  11. Kalinchenko S.Yu., Apetov S.S. Rol` androgenov u zhenshhin: chto my znaem? // Lechashhiy vrach. – 2010; 8: 78–83 [Kalinchenko S.Yu., Apetov S.S. Rol' androgenov u zhenshchin: chto my znayem? // Lechashchiy vrach. – 2010; 8: 78–83 (in Russ.)]
  12. Zumoff B., Strain G., Miller L. et al. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women // J. Clin. Endocrinol. Metab. – 1995; 80: 1429–30.